Arquivos do dia: Novembro 19, 2021
Estudo RECOVERY | Aspirina como terapia complementar não reduziu a mortalidade em pacientes internados com COVID-19.
19 Nov, 2021 | 13:20hComentário convidado: Studying the coagulopathy of COVID-19 – The Lancet
Comentário do autor no Twitter (fio – clique para saber mais)
RECOVERY Publication: ASPIRIN
(a widely used anti-platelet treatment in other settings)14 892 patients hospitalised with COVID-19.
No impact on mortality.
Small improvement in hospital stay.
No impact on need for mechanical ventilation
6 more bleeds. 6 fewer thromboses (clots) pic.twitter.com/LxDzudss9F— Martin Landray (@MartinLandray) November 18, 2021
Revisitando as políticas de COVID-19: 10 recomendações baseadas em evidências para seguir daqui em diante.
19 Nov, 2021 | 13:19hEditorial | Vacinas contra COVID-19 para crianças – “Embora seja verdade que a maioria das crianças tenham doença assintomática ou leve, algumas ficarão bastante doentes e um pequeno número irá a óbito. Este é o motivo de crianças serem vacinadas contra gripe, meningite, catapora e hepatite.”
19 Nov, 2021 | 13:17hCOVID-19 vaccines for children – Science
Conteúdo relacionado: Review: Should children under 12 years of age be vaccinated against COVID-19?
Comentário no Twitter
"Although it is true that most children experience asymptomatic or mild COVID disease, some will get quite sick, and a small number will die.
It’s why children are vaccinated against influenza, meningitis, chickenpox, and hepatitis" @DrPaulOffit et al.https://t.co/mvXHXdiYha
— Madhu Pai, MD, PhD (@paimadhu) November 18, 2021
Revisão | Calculando o custo neurológico da COVID-19.
19 Nov, 2021 | 13:15hCounting the neurological cost of COVID-19 – Nature Reviews Neurology
Comentário no Twitter
In our latest News & Views, Abdul Mannan Baig discusses how the neurological manifestations of COVID-19 are expected to increase the burden of morbidity and mortality. #NewfromNRNeurology https://t.co/DNc6B1OBpM
— Nat Rev Neurology (@NatRevNeurol) November 18, 2021
Progresso global da tuberculose foi revertido pela pandemia de COVID-19.
19 Nov, 2021 | 13:14hGlobal tuberculosis progress reversed by COVID-19 pandemic – The Lancet Respiratory Diseases
Conteúdos relacionados:
How COVID is derailing the fight against HIV, TB and malaria.
How COVID hurt the fight against other dangerous diseases
World TB Day | Report: COVID-19 Eliminates Twelve Years of Progress Against Tuberculosis
Tuberculosis and Covid-19: Fighting a deadly syndemic
Comentário no Twitter
NEWS—Global #tuberculosis progress reversed by #COVID19 pandemic
"Due to the delayed effects from #COVID19, #tuberculosis deaths are projected to rise again in 2022 while the world readjusts to a new normality and services resume."
Read more here: https://t.co/tWVXswZsvs
— The Lancet Respiratory Medicine (@LancetRespirMed) November 3, 2021
Perspectiva | O futuro da vacinação contra SARS-CoV-2 – Lições da Influenza.
19 Nov, 2021 | 13:12hThe Future of SARS-CoV-2 Vaccination — Lessons from Influenza – New England Journal of Medicine
Correlação entre o aumento de infecções por SARS-CoV-2 e o tempo de vacinação.
19 Nov, 2021 | 13:11hCorrelation of SARS-CoV-2-breakthrough infections to time-from-vaccine – Nature Communications
Comentário: Long-term effectiveness of Pfizer/BioNTech two-dose regimen mRNA vaccine – News Medical
China’s COVID vaccines have been crucial — now immunity is waning.
Editorial | Covid-19 vaccination: evidence of waning immunity is overstated.
COVID vaccine effects wane over time but still prevent death and severe illness.
Perspective | What we actually know about waning immunity.
Another study shows Pfizer mRNA vaccine immunity is reduced over time.
Studies: COVID vaccine protection waning against infection but not hospitalization.
Comentário no Twitter
A paper in @NatureComms presents preliminary evidence of Pfizer-BioNTech COVID-19 vaccine waning, with a higher incidence of breakthrough infection in people who received their second dose early in 2021 compared to later in the year. https://t.co/QJ7sPZIDuC pic.twitter.com/Gwkj0ugz57
— Nature Portfolio (@NaturePortfolio) November 18, 2021
Opinião | Com 128 vacinas contra Covid em desenvolvimento clínico, não se sabe se as aprovadas/autorizadas são as melhores.
19 Nov, 2021 | 13:09hRelatório global da OMS sobre a prevalência do tabagismo, 2000-2025.
19 Nov, 2021 | 13:08hComunicado de imprensa: Tobacco use falling: WHO urges countries to invest in helping more people to quit tobacco – World Health Organization
Comentário no Twitter
Tobacco use is falling by 5⃣ million people per year
🆕 WHO global tobacco trends report released today, shows that there are 1.3 billion tobacco users 🌐 compared to 1.32 billion in 2015, & expected to ↘️ to 1.27 billion by 2025.
👉 https://t.co/o3bdYaQy84#CommitToQuit 🚭 pic.twitter.com/gSJebhRtYY
— World Health Organization (WHO) (@WHO) November 16, 2021
Causas globais, regionais e nacionais da mortalidade infantil (menores de 5 anos) em 2000-2019: análise sistemática atualizada com implicações para as Metas de Desenvolvimento Sustentável.
19 Nov, 2021 | 13:07h
Comentário no Twitter
Progress is still needed to improve child health and end preventable deaths among children <5 years
New cause-specific estimates of infant mortality for 2000-19 are explored in this Article by Jamie Perin and colleagues @JohnsHopkinsSPH, @LSHTM & @WHO https://t.co/QJEDAd5jYT pic.twitter.com/Wis0v8YSav
— The Lancet Child & Adolescent Health (@LancetChildAdol) November 18, 2021
Pneumonia remains #1 postneonatal killer for children <5. Most deaths occur in children who live in poverty or humanitarian settings, have poor access to quality care, are malnourished & unimmunised. Many health centres don’t have antibiotics or O2. It’s 2021 not the Middle Ages. https://t.co/P7EhDN9KJ2
— Fiona Russell (@Fiona_M_Russell) November 18, 2021